173 related articles for article (PubMed ID: 14520703)
1. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.
Alguacil J; Porta M; Kauppinen T; Malats N; Kogevinas M; Carrato A;
Int J Cancer; 2003 Nov; 107(4):635-41. PubMed ID: 14520703
[TBL] [Abstract][Full Text] [Related]
2. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer.
Alguacil J; Porta M; Malats N; Kauppinen T; Kogevinas M; Benavides FG; Partanen T; Carrato A;
Carcinogenesis; 2002 Jan; 23(1):101-6. PubMed ID: 11756230
[TBL] [Abstract][Full Text] [Related]
3. Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group.
Alguacil J; Kauppinen T; Porta M; Partanen T; Malats N; Kogevinas M; Benavides FG; Obiols J; Bernal F; Rifà J; Carrato A
Ann Occup Hyg; 2000 Aug; 44(5):391-403. PubMed ID: 10930502
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
Porta M; Malats N; Jariod M; Grimalt JO; Rifà J; Carrato A; Guarner L; Salas A; Santiago-Silva M; Corominas JM; Andreu M; Real FX
Lancet; 1999 Dec 18-25; 354(9196):2125-9. PubMed ID: 10609819
[TBL] [Abstract][Full Text] [Related]
5. Toenail concentrations of trace elements and occupational history in pancreatic cancer.
Camargo J; Pumarega JA; Alguacil J; Sanz-Gallén P; Gasull M; Delclos GL; Amaral AFS; Porta M
Environ Int; 2019 Jun; 127():216-225. PubMed ID: 30928845
[TBL] [Abstract][Full Text] [Related]
6. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer.
Crous-Bou M; Porta M; López T; Jariod M; Malats N; Alguacil J; Morales E; Fernandez E; Corominas JM; Carrato A; Guarner L; Real FX;
Pancreas; 2007 Aug; 35(2):135-41. PubMed ID: 17632319
[TBL] [Abstract][Full Text] [Related]
7. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
[TBL] [Abstract][Full Text] [Related]
8. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos.
Husgafvel-Pursiainen K; Hackman P; Ridanpää M; Anttila S; Karjalainen A; Partanen T; Taikina-Aho O; Heikkilä L; Vainio H
Int J Cancer; 1993 Jan; 53(2):250-6. PubMed ID: 8425762
[TBL] [Abstract][Full Text] [Related]
10. [K-ras gene mutations of asbestos and welding-fumes related human lung cancer].
Huang B; Liu B; Xu M; You B
Wei Sheng Yan Jiu; 2000 Jan; 29(1):7-9. PubMed ID: 12725029
[TBL] [Abstract][Full Text] [Related]
11. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
[TBL] [Abstract][Full Text] [Related]
12. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Shu XO; Perentesis JP; Wen W; Buckley JD; Boyle E; Ross JA; Robison LL;
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1230-5. PubMed ID: 15247135
[TBL] [Abstract][Full Text] [Related]
13. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
Porta M; Malats N; Guarner L; Carrato A; Rifà J; Salas A; Corominas JM; Andreu M; Real FX
J Epidemiol Community Health; 1999 Nov; 53(11):702-9. PubMed ID: 10656099
[TBL] [Abstract][Full Text] [Related]
14. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN
Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263
[TBL] [Abstract][Full Text] [Related]
15. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
[TBL] [Abstract][Full Text] [Related]
16. Parental occupational exposure to combustion products, metals, silica and asbestos and risk of childhood leukaemia: Findings from the Childhood Cancer and Leukaemia International Consortium (CLIC).
Onyije FM; Olsson A; Erdmann F; Magnani C; Petridou E; Clavel J; Miligi L; Bonaventure A; Ferrante D; Piro S; Peters S; Vermeulen R; Kromhout H; Schüz J;
Environ Int; 2022 Sep; 167():107409. PubMed ID: 35908390
[TBL] [Abstract][Full Text] [Related]
17. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.
Theodor L; Melzer E; Sologov M; Idelman G; Friedman E; Bar-Meir S
Dig Dis Sci; 1999 Oct; 44(10):2014-9. PubMed ID: 10548352
[TBL] [Abstract][Full Text] [Related]
18. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
[TBL] [Abstract][Full Text] [Related]
20. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
